• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Virol. Interferon-induced ISG15 conjugation inhibits influenza A virus gene expression and replication in human cells.

Giuseppe

Emeritus
J Virol. 2009 Apr 8. [Epub ahead of print]

Interferon-induced ISG15 conjugation inhibits influenza A virus gene expression and replication in human cells.

Hsiang TY, Zhao C, Krug RM. - Institute for Cellular and Molecular Biology, Section of Molecular Genetics and Microbiology, University of Texas at Austin, Austin, Texas 78712 USA.

The ubiquitin-like ISG15 protein, as well as its conjugating enzymes, are induced by type I interferons (IFNs). Experiments using ISG15-knockout (ISG15-/-) mice established that ISG15 and/or its conjugation inhibits the replication of influenza A virus.
However, in contrast to the virus inhibition results in the mice, the rate of virus replication was similar in ISG15+/+ and ISG15-/- mouse embryo fibroblasts in tissue culture. Here we focus on human tissue culture cells and on the effect of ISG15 and/or its conjugation on influenza A virus gene expression and replication in such cells.
We demonstrate that IFN-induced antiviral activity against influenza A virus in human cells is significantly alleviated by inhibiting ISG15 conjugation using small interfering RNAs (siRNAs) directed against ISG15 conjugating enzymes. IFN-induced antiviral activity against influenza A virus protein synthesis was reduced 5-20 fold by suppressing ISG15 conjugation.
The amounts of the viral proteins that were restored by these siRNA treatments were approximately 40-50% of the amounts produced in cells that were not pretreated with IFN. Further, we show that ISG15 conjugation inhibits influenza A virus replication 10-20-fold at early times after infection in human cells.
These results show that ISG15 conjugation plays a substantial role in the antiviral state induced by IFN in human cells. In contrast, we show that in mouse embryo fibroblasts ISG15 conjugation not only does not affect influenza A virus replication but also does not contribute to the IFN-induced antiviral activity against influenza A virus gene expression.

PMID: 19357168 [PubMed - as supplied by publisher]
-
------
 
Back
Top